Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.6.3.1 (
NADPH oxidase
)
11,281
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Heparin cofactor II
(
HCII
), a serine protease inhibitor, inhibits tissue thrombin action after binding with dermatan sulfate proteoglycans in the extracellular matrix of the vascular system. We previously reported that heterozygous
HCII
-deficient (
HCII
(+/-)) humans and mice demonstrate acceleration of vascular remodeling, including atherosclerosis. However, the action of
HCII
on cardiac remodeling never has been determined.
HCII
(+/+) and
HCII
(+/-) mice at age 25 weeks were infused with angiotensin II (Ang II; 2.0 mg/kg/d) for 2 weeks by an osmotic mini-pump. Echocardiography revealed acceleration of cardiac concentric remodeling in
HCII
(+/-) mice and larger left atrial volume in
HCII
(+/-) mice than in
HCII
(+/+) mice. Histopathologic studies showed more prominent interstitial fibrosis in both the left atrium and left ventricle in
HCII
(+/-) mice than in
HCII
(+/+) mice. Daily urinary excretion of 8-hydroxy-2'-deoxyguanosine, a parameter of oxidative stress, and dihydroethidium-positive spots, indicating superoxide production in the myocardium, were markedly increased in Ang II-treated
HCII
(+/-) mice compared to those in
HCII
(+/+) mice. Cardiac gene expression levels of atrial natriuretic peptides and brain natriuretic peptides, members of the natriuretic peptide family, Nox 4, Rac-1, and p67(phox) as components of
NAD(P)H oxidase
, and transforming growth factor-beta1 and procollagen III were more augmented in
HCII
(+/-) mice than in
HCII
(+/+) mice. However, administration of human
HCII
protein attenuated all of those abnormalities in Ang II-treated
HCII
(+/-) mice. Moreover, human
HCII
protein supplementation almost abolished cardiac fibrosis in Ang II-treated
HCII
(+/+) mice. The results indicate that
HCII
has a protective role against Ang II-induced cardiac remodeling through suppression of the
NAD(P)H oxidase
-transforming growth factor-beta1 pathway.
...
PMID:Heparin cofactor II protects against angiotensin II-induced cardiac remodeling via attenuation of oxidative stress in mice. 2066 Aug 21